A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Isolating Primary Melanocyte-like Cells from the Mouse Heart

10.2K views

⸱

DOI:

10.3791/4357

⸱

September 29th, 2014

 ,  ,  , 

In This Article

Summary

In this protocol, we identified a novel population of melanocyte-like cells (also known as cardiac melanocytes) in the hearts of mice and humans that contribute to atrial arrhythmia triggers in mice. 

Abstract

We identified a novel population of melanocyte-like cells (also known as cardiac melanocytes) in the hearts of mice and humans that contribute to atrial arrhythmia triggers in mice. To investigate the electrical and biological properties of cardiac melanocytes we developed a procedure to isolate them from mouse hearts that we derived from those designed to isolate neonatal murine cardiomyocytes. In order to obtain healthier cardiac melanocytes suitable for more extensive patch clamp or biochemical studies, we developed a refined procedure for isolating and plating cardiac melanocytes based on those originally designed to isolate cutaneous melanocytes. The refined procedure is demonstrated in this review and produces larger numbers of healthy melanocyte-like cells that can be plated as a pure population or with cardiomyocytes.

Introduction

We recently identified a novel cell population in the heart of mice and humans that express melanin-synthesis enzymes and morphologically resemble cutaneous melanocytes. We called these cells 'cardiac melanocytes' and found they are present in anatomic locations from which atrial arrhythmia triggers often originate in humans. We also found cardiac melanocytes contribute to atrial arrhythmias in mice with germline deletion of Dct. Cardiac melanocytes are sparsely distributed throughout the mouse atrium where they comprise less than 0.1% of all atrial cells. To investigate the electrical and biological properties of cardiac melanocytes we developed a procedure t....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Preparing the Necessary Solutions and Equipment

  1. First, sterilize the surgical instruments (straight shape forceps, curved shape forceps, straight shape scissors, and curved shape scissors) by autoclaving them for 15 min. at 121 °C. Prepare 2 sets of instruments, where one set is used for dissecting out the hearts and the other set will be used for mincing up the tissue.
  2. Dissolve 1 packet of MCDB153 culture media in 900 ml of sterilized, filtered water and stir slowly until the powder has dissolved. Add 1.2 g sodium bicarbonate, or 15.7 ml of sodium bicarbonate solution [7.5% w/v], for each liter of final volume of medium being prepared an....

Access restricted. Please log in or start a trial to view this content.

Results

The protocol described in this article is an improved technique compared to the one we previously published for isolating cardiac melanocytes from the murine heart. This procedure employs the use of fluorescent markers driven by melanin synthesis enzyme-specific Cre-recombinase to label cardiac melanocyte-like cells. It is important to use a marker to label cardiac melanocytes when working with freshly isolated embryonic or neonatal cells, since the morphological differences that distinguish cardiac melanocytes from atri.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Cardiac melanocytes are present in anatomic locations within the heart that commonly give rise to atrial arrhythmia triggers. These regions include the pulmonary veins, the atrioventricular annulus, the posterior left atrium and the foramen ovale (Figure 4). To understand the role these cells play in arrhythmogenesis, we develop techniques to isolate them and study their physiology. However, we recognized that improving this technique to yield healthier and larger quantities of cardiac melanocytes would .......

Access restricted. Please log in or start a trial to view this content.

Disclosures

We have nothing to disclose.

Acknowledgements

This work was supported by National Institutes of Health award R01 HL105734 to V.V.P. M.D.L. is supported, in part, by National Institutes of Health Research Career Award K08 HL094748. V.V.P. is an Innovative Researcher of the American Heart Association supported by grant 11IRG900384.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
MCDB 153Sigma-AldrichM7403Dissolve in water
DPBS, no calcium no magnesiumInvitrogen14190136Stock conc.: 1x
Working conc.: 1x
Penicillin-streptomycin Invitrogen15140163Stock conc.: 100x
Working conc.: 1x
Fetal Bovine SerumLife TechnologyCertifiedWorking conc.: 4%
TPASigma-AldrichP1585Dissolve in DMSO
Stock conc.: 3.2 μM
Working conc.: 32 nM
TransferrinSigma-AldrichT8158Dissolve in DPBS
Stock conc.: 0.1 mg/ml
Working conc.: 1 μg/ml
Dibutyryl cyclic AMPSigma-AldrichD0627Dissolve in DPBS
Stock conc.: 0.5 mM
Working conc.: 5 μM
InsulinSigma-AldrichI6634Dissolve in 10 mM acetic acid
Stock conc.: 1 mg/ml
Working conc.: 5 μg/ml
Basic FGFBD Biosciences354060Dissolve in water
Stock conc.: 4 ng/μl
Working conc.: 4 ng/ml

References

  1. Hornyak, T. J., et al. Mitf dosage as a primary determinant of melanocyte survival after ultraviolet irradiation. Pigment Cell Melanoma Res. 22, 307-318 (2009).
  2. Yonetani, S., et al.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Cardiac MelanocytesMelanocyte IsolationHeart Tissue DigestionEnzymatic DissociationCell Culture ProcedureTrypsin SolutionDPBS Supplement40 Micron StrainerNeonatal Mouse HeartsPatch Clamp Analysis